Mitochondrial TCA cycle metabolites control physiology and disease

[문형철]

1. nature  
2. nature communications  
3. review articles  
4. article

Mitochondrial TCA cycle metabolites control physiology and disease

Download PDF

• Review Article
• Open access
• Published: 03 January 2020

Mitochondrial TCA cycle metabolites control physiology and disease

• Inmaculada Martínez-Reyes & 
• Navdeep S. Chandel 

Nature Communications volume 11, Article number: 102 (2020) Cite this article

• 165k Accesses

• 1036 Citations

• 171 Altmetric

• Metricsdetails

Abstract

Mitochondria are signaling organelles that regulate a wide variety of cellular functions and can dictate cell fate. Multiple mechanisms contribute to communicate mitochondrial fitness to the rest of the cell. Recent evidence confers a new role for TCA cycle intermediates, generally thought to be important for biosynthetic purposes, as signaling molecules with functions controlling chromatin modifications, DNA methylation, the hypoxic response, and immunity. This review summarizes the mechanisms by which the abundance of different TCA cycle metabolites controls cellular function and fate in different contexts. We will focus on how these metabolites mediated signaling can affect physiology and disease.

미토콘드리아는 

다양한 세포 기능을 조절하고 

세포의 운명을 좌우할 수 있는 신호 전달 기관입니다. 

여러 메커니즘이 

미토콘드리아의 건강 상태를 

세포의 나머지 부분으로 전달하는 데 기여합니다. 

최근의 증거는 일반적으로 

생합성 목적에 중요하다고 여겨지는

 TCA 주기 중간체에

염색질 변형,

 DNA 메틸화, 

저산소 반응 및 

면역을 조절하는 기능을 가진 신호 분자로서 

새로운 역할을 부여합니다. 

이 리뷰에서는 

다양한 TCA 주기 대사 산물의 풍부함이 

다양한 맥락에서 세포 기능과 

운명을 조절하는 메커니즘을 요약합니다. 

이러한 대사산물을 매개로 한 신호 전달이 

생리와 질병에 어떻게 영향을 미치는지 집중적으로 살펴봅니다.

Similar content being viewed by others

7-Dehydrocholesterol is an endogenous suppressor of ferroptosis

Article 31 January 2024

7-Dehydrocholesterol dictates ferroptosis sensitivity

Article 31 January 2024

Stress response silencing by an E3 ligase mutated in neurodegeneration

Article Open access31 January 2024

Introduction

Mitochondria are cellular organelles that generate ATP and metabolites for survival and growth, respectively. Mitochondria are responsive to execution of commands from the nucleus. Gene expression‎ changes from the nucleus promote mitochondrial biogenesis or increase mitochondrial respiratory activity to meet the cellular needs through a mechanism called “anterograde regulation”. However, it is clear now that mitochondria and the nucleus maintain a bidirectional regulation. Cells check whether mitochondrial metabolism is fit before they engage in complex and highly demanding cellular functions, including differentiation or adaptation to stress. Through a “retrograde signaling” mitochondria can regulate the expression‎ of different genes to facilitate diverse cellular functions1. The mitochondrial requirements are diverse among different cell types and they are highly influenced by the microenvironment.

미토콘드리아는 

생존과 성장을 위해 

각각 ATP와 대사산물을 생성하는 세포 소기관입니다. 

미토콘드리아는 

핵의 명령 실행에 반응합니다. 

핵으로부터의 유전자 발현 변화는

 '후성 조절'이라는 메커니즘을 통해 

미토콘드리아의 생성을 촉진하거나 

미토콘드리아의 호흡 활동을 증가시켜 

세포의 요구를 충족시킵니다. 

그러나 이제는 

미토콘드리아와 핵이 

양방향 조절을 유지한다는 것이 분명해졌습니다. 

세포는 

분화나 스트레스에 대한 적응 등 

복잡하고 까다로운 세포 기능을 수행하기 전에 

미토콘드리아의 대사가 적합한지 여부를 확인합니다. 

미토콘드리아는 

"역행 신호"를 통해 다양한 유전자의 발현을 조절하여 

다양한 세포 기능을 촉진할 수 있습니다1. 

미토콘드리아의 요구 사항은 

세포 유형에 따라 다양하며 

미세 환경의 영향을 많이 받습니다.

Four prominent mechanisms by which mitochondria communicate with the rest of the cell include the

release of cytochrome c to induce cell death,

activation of AMP-activated protein kinase (AMPK) to control mitochondrial fission and fusion,

production of reactive oxygen species (ROS) to activate transcription factors, and

the release of mitochondrial DNA (mtDNA) to activate immune responses2,3,4,5 (Fig. 1).

Recent studies indicate a fifth mechanism whereby

mitochondria release TCA (tricarboxylic acid) cycle metabolites

to control cell fate and function (Fig. 2).

TCA cycle metabolites were primarily considered as byproducts of cellular metabolism important for the biosynthesis of macromolecules such as nucleotides, lipids, and proteins. Although this is an essential function for the maintenance of cellular homeostasis, it is rapidly appreciated that metabolites in the TCA cycle are also involved in controlling chromatin modifications, DNA methylation, and post-translational modifications of proteins to alter their function. The purpose of this review is to highlight the signaling implications of TCA cycle metabolites and how changes in their abundance control physiology and disease.

미토콘드리아가 

세포의 나머지 부분과 소통하는 

네 가지 주요 메커니즘에는 

세포 사멸을 유도하는 사이토크롬 c의 방출, 

미토콘드리아 분열과 융합을 제어하는 AMP 활성화 단백질 키나제(AMPK)의 활성화, 

전사인자를 활성화하는 활성 산소 종(ROS)의 생성, 

면역 반응을 활성화하는 미토콘드리아 DNA(mtDNA)의 방출2,3,4,5이 있습니다(그림 1 참조). 

최근 연구에 따르면 

미토콘드리아가 

TCA(트리카르복실산) 주기 대사산물을 방출하여 

세포의 운명과 기능을 조절하는 

다섯 번째 메커니즘이 밝혀졌습니다(그림 2). 

TCA 주기 대사 산물은 주로 

뉴클레오타이드, 

지질, 

단백질과 같은 거대 분자의 생합성에 중요한 

세포 대사의 부산물로 간주되었습니다. 

이는 

세포 항상성 유지에 필수적인 기능이지만, 

TCA 주기의 대사 산물이 

염색질 변형, 

DNA 메틸화 및 

단백질의 번역 후 변형을 조절하여 

기능을 변화시키는 데도 관여한다는 사실이 

빠르게 인식되고 있습니다. 

이 리뷰의 목적은 

TCA 주기 대사 산물의 신호 전달과 

양의 변화가 생리와 질병을 어떻게 조절하는지를

강조하는 것입니다.

Fig. 1: Essential signaling functions of mitochondria.

Mitochondria have evolved distinct strategies to integrate environmental cues and communicate their fitness to the rest of the cell to maintain cellular homeostasis. Release of cytochrome c to invoke caspase-dependent cell death, release of reactive oxygen species to oxidize thiols within redox-regulated proteins, and induce gene expression‎ and the activation of AMPK under energetic stress to control mitochondrial dynamics are three prominent mitochondrial-dependent signaling events. Additionally, release of mitochondrial DNA into the cytosol triggers inflammasome activation and pro-inflammatory responses through the cGAS–STING cytosolic DNA-sensing pathway. Signaling roles of TCA cycle metabolites are in part mediated by controlling chromatin modifications and DNA methylation, as well as post-translational protein modifications.

미토콘드리아는 

세포 항상성을 유지하기 위해 

환경 신호를 통합하고 

자신의 건강 상태를 세포의 나머지 부분과 소통하는 

독특한 전략을 진화시켜 왔습니다. 

카스파제에 의존하는 세포 사멸을 유발하는 사이토크롬 c의 방출, 

산화 환원 조절 단백질 내의 티올을 산화시키는 활성 산소 종의 방출, 

미토콘드리아의 역학을 제어하기 위해 에너지 스트레스 하에서 유전자 발현과 

AMPK의 활성화를 유도하는 것은 

미토콘드리아에 의한 세 가지 대표적인 신호 신호 사건입니다. 

또한 미토콘드리아 DNA가 

세포질로 방출되면 

cGAS-STING 세포질 DNA 감지 경로를 통해 

인플라마좀 활성화와 염증 반응을 촉발합니다. 

TCA 주기 대사 산물의 신호 역할은 

부분적으로 염색질 변형과 

DNA 메틸화, 

번역 후 단백질 변형을 제어함으로써 

매개됩니다.

Fig. 2: The TCA cycle is a signaling hub.

TCA cycle metabolites have diverse non-metabolic signaling roles with important effects in physiology and disease. Metabolites such as acetyl-CoA, itaconate, succinate, fumarate, and L-2-HG can alter the response of both the innate and adaptive immune systems. Other functions like lymphangiogenesis or the maintenance of stem cells pluripotency have been associated with acetyl-CoA and α-KG, respectively. Succinate, L-2HG, and fumarate are well recognized oncometabolites that promote tumorigenesis. In addition to its intracellular functions, succinate can also act as a systemic signal to regulate thermogenesis upon exposure to cold temperature.

TCA 주기 대사산물은 생

리와 질병에 중요한 영향을 미치는 

다양한 비대사적 신호 전달 역할을 합니다. 

아세틸-CoA, 

이타코네이트, 

숙시네이트, 

푸마르산염, 

L-2-HG와 같은 대사산물은 

선천성 면역계와 후천성 면역계의 반응을 변화시킬 수 있습니다. 

림프관 형성이나 

줄기세포 만능성 유지와 같은 다른 기능도 

각각 아세틸-CoA와 α-KG와 관련이 있습니다. 

숙시네이트, 

L-2HG, 

푸마레이트는 

종양 형성을 촉진하는 종양 대사 물질로 잘 알려져 있습니다. 

숙시네이트는 

세포 내 기능 외에도 

저온 노출 시 열 발생을 조절하는 

전신 신호로도 작용할 수 있습니다.

The TCA cycle and its regulation

The TCA cycle overview

The TCA cycle, also known as the citric acid cycle or the Krebs cycle, is a series of reactions in a closed loop that forms a metabolic engine within cells (Fig. 3). The TCA cycle constitutes an epicenter in cell metabolism because multiple substrates can feed into it. The TCA cycle begins with the reaction that combines the two-carbon acetyl-CoA, generated from fatty acids, amino acids or pyruvate oxidation, with a four-carbon oxaloacetate (OAA) to generate the six-carbon molecule citrate. In the second step, citrate is converted into its isomer, isocitrate. The cycle continues with two oxidative decarboxylation in which isocitrate is converted into the five-carbon α-ketoglutarate (α-KG) and subsequently into the four-carbon succinyl-CoA with the release of two molecules of CO2 and the generation of two NADH molecules. Next, succinyl-CoA converts into succinate, coupling it to the generation of GTP, which can be converted into ATP. Succinate is oxidized generating the four-carbon molecule fumarate. In this reaction, two hydrogen atoms are transferred to FAD, producing 2FADH. Importantly, the enzyme that carries out this step, succinate dehydrogenase (SDH), is also part of the electron transport chain (ETC) (Fig. 3). Next, fumarate gets converted into malate and further into OAA that combine with another acetyl-CoA molecule to continue the TCA cycle.

구연산 주기 또는 크렙스 주기로도 알려진 TCA 주기는 

세포 내에서 대사 엔진을 형성하는 

폐쇄 루프에서 일어나는 일련의 반응입니다(그림 3). 

TCA 순환은 

여러 기질이 공급될 수 있기 때문에 

세포 대사의 진원지 역할을 합니다. 

TCA 순환은 

지방산, 

아미노산 또는 피루브산 산화로 생성된 

2탄소 아세틸-CoA를 4탄소 옥살로아세테이트(OAA)와 결합하여 

6탄소 분자 구연산염을 생성하는 반응으로 시작됩니다. 

두 번째 단계에서는 

구연산염이 이성질체인 

이소시트레이트로 전환됩니다. 

이 사이클은 

이소시트레이트가 5탄소 α-케토글루타레이트(α-KG)로 전환된 다음 

두 번의 산화 탈카르복실화를 거쳐 

두 분자의 CO2 방출과 두 개의 NADH 분자를 생성하여 

4탄소 석시닐-CoA로 전환되는 

두 번의 산화 탈카르복실화로 이어집니다. 

다음으로, 

숙시닐-CoA는 숙시네이트로 전환되어 

ATP로 전환될 수 있는 GTP 생성에 결합합니다. 

숙시네이트는 

산화되어 4탄소 분자 푸마르산염을 생성합니다. 

이 반응에서 

두 개의 수소 원자가 FAD로 옮겨져 2FADH가 생성됩니다. 

중요한 것은 

이 단계를 수행하는 효소인 

숙시네이트 탈수소효소(SDH)도 

전자 수송 사슬(ETC)의 일부라는 점입니다(그림 3). 

다음으로 

푸마레이트는 말레이트로 전환되고 

다른 아세틸-CoA 분자와 결합하여 OAA로 전환되어 TCA 사이클을 계속합니다.

Fig. 3: The TCA cycle and OXPHOS are tightly coordinated.

In a series of enzymatic reactions the TCA cycle generates the reducing equivalents NADH and FADH2, which are required to transfer electrons to the mitochondrial respiratory chain, also known as the electron transport chain (ETC). As the electrons are funneled through the complexes in the inner mitochondrial membrane, a functional ETC generates a mitochondrial membrane potential that is used to produce ATP. This process requires the presence of oxygen and it is known as oxidative phosphorylation (OXPHOS). Mitochondrial complex I and II in the ETC replenish NAD + and FAD, respectively, allowing the oxidative TCA cycle to function. Succinate dehydrogenase is the only enzyme that participates in both the TCA cycle and the ETC.

일련의 효소 반응에서 TCA 주기는 

전자 수송 사슬(ETC)이라고도 하는 

미토콘드리아 호흡 사슬에 전자를 전달하는 데 

필요한 환원 등가물인 NADH와 FADH2를 생성합니다. 

전자가 

미토콘드리아 막 내부의 복합체를 통과할 때, 

기능적인 ETC는 ATP를 생성하는 데 

사용되는 미토콘드리아 막 전위를 생성합니다. 

이 과정은 

산소의 존재가 필요하며 

이를 산화적 인산화(OXPHOS)라고 합니다. 

ETC의 미토콘드리아 복합체 I과 II는 

각각 NAD +와 FAD를 보충하여 

산화적 TCA 사이클이 작동할 수 있도록 합니다. 

숙시네이트 탈수소효소는 

TCA 주기와 ETC에 모두 관여하는 유일한 효소입니다.

The TCA cycle participates in both anabolism and catabolism

As the cycle runs, metabolites from the cycle are transported into the cytosol where they provide the building blocks for macromolecule synthesis6. For example, citrate is exported to the cytosol where it is converted to OAA and acetyl-CoA to promote nucleotide and lipid synthesis, respectively. Importantly, when TCA cycle intermediates are being shuttled away from the mitochondria for biosynthetic purposes, the cycle has to be replenished to keep it running. This process is referred to as anaplerosis. There are multiple inputs into the TCA cycle but two important anaplerotic mechanisms are the conversion of pyruvate to mitochondrial OAA by pyruvate decarboxylase and the activation of glutaminolysis, which converts glutamine to glutamate and subsequently to α-KG. The latter mechanism is often used when α-KG levels drop due to citrate being exported from the mitochondria into the cytosol for the de novo lipid synthesis. Interestingly, in cases where the ETC is impaired, the generation of some TCA cycle intermediates can be maintained by a process called glutamine-dependent reductive carboxylation7. In this pathway the cycle partially reverses itself to generate citrate from glutamine-derived α-KG by two subsequent reactions catalyzed by NADPH-dependent isocitrate dehydrogenase 2 (IDH2) and aconitase (ACO).

Enzymes of the TCA cycle evolved prior to the presence of oxygen on earth signifying the primary biosynthetic role of the TCA cycle. However, over time the TCA cycle has evolved into an important energy-producing pathway in eukaryotes. The primary function of one turn of the TCA cycle from an energy-generating perspective is to oxidize acetyl-CoA to two molecules of CO2. The completion of the TCA cycle generates ATP and the byproducts 3 NADH and 1 FADH2 that further feed the ETC complex I (NADH dehydrogenase) and complex II (SDH), respectively. Complexes I and II then pass their electrons through the ETC to ultimately produce ATP through oxidative phosphorylation (OXPHOS). The TCA cycle and OXPHOS are coupled since the oxidation of NADH and FADH2 in complexes I and II is required for the TCA cycle to keep functioning (Fig. 3).

The TCA cycle is a tightly regulated pathway

The regulation of the TCA cycle and its constant feedback with OXPHOS is critical to keep the cells in a stable state. There are multiple positive and negative allosteric regulators that control the metabolic flux of the TCA cycle. NADH inhibits all the regulatory enzymes in the TCA cycle. Thus, in situations of ETC malfunctioning, NADH accumulates and the TCA cycle shuts down as a consequence. As NADH generates ATP through the ETC and OXPHOS, ATP is also an allosteric inhibitor of pyruvate dehydrogenase (PDH) and IDH. Thus, when cells have ample NADH and ATP, the cycle slows down. In contrast, high demands for ATP increases the ADP/ATP ratio and AMP levels, resulting in stimulation of the regulatory enzymes of the TCA cycle. Abundant acetyl-CoA inhibits PDH but activates pyruvate carboxylase to increase the formation of OAA from pyruvate and thus pair the levels of the two initiating metabolites of the cycle. Another intrinsic regulator is succinyl-CoA, which inhibits both citrate synthase and α-KG dehydrogenase to slow the cycle down. Likewise, an increase in OAA inhibits SDH and decelerates the cycle.

The TCA cycle and cellular signaling

Acetyl-CoA

Acetyl-CoA is a thioester between the two-carbon acetyl group (CH3CO) and a thiol, coenzyme A (CoA). As mentioned in the previous section, the maintenance of an acetyl-CoA pool is crucial to sustain the TCA cycle activity. To achieve this, acetyl-CoA can be generated from different sources and in multiple compartments. In mitochondria, acetyl-CoA can be generated from the oxidation of pyruvate, through fatty acid oxidation, by the degradation of the amino acids leucine, isoleucine, and tryptophan or through the mitochondrial enzyme aceyl-CoA synthetase short-chain family, member 1 (ACSS1)-mediated conversion of acetate. Acetyl-CoA can also be generated in the cytosol. Citrate can travel outside of the mitochondria through the dicarboxylate antiporter solute carrier family 25 (SLC25A1) and be converted back to acetyl-CoA and OAA by ATP citrate lyase (ACLY) both in the cytosol and in the nucleus. Finally, the cytosolic enzyme aceyl-CoA synthetase short-chain family, member 2 (ACSS2) can metabolize acetate into acetyl-CoA. Although this is not a common physiological pathway except in hepatocytes, cancer cells rely on this pathway to respond to the metabolic stress caused by limited nutrient availability8,9. The versatile participation of acetyl-CoA in multiple cellular processes makes it a critical metabolite to maintain cell homeostasis. Acetyl-CoA acts as a metabolic intermediate and as a precursor of anabolic reactions in the synthesis of fatty acids and steroids, and certain amino acids, including glutamate, proline, and arginine.

Acetyl-CoA regulates chromatin dynamics

Likely the most prominent signaling function of acetyl-CoA is related to its ability to provide the acetyl groups for acetylation, one of the major post-translational protein modifications in the cell. Special attention has been paid to the contribution of acetyl-CoA as a necessary cofactor in the acetylation of histones, a mechanism known to alter the dynamics of chromatin to drive the epigenetic control of gene expression‎ by activating transcriptional programs10, 11 (Fig. 4). Histone acetyltransferases (HATs) are the enzymes responsible for catalyzing the addition of acetyl groups in the histone N-terminal tails. The activity of HATs is sensitive to changes in the acetyl-CoA levels, which are in turn highly dependent on glucose availability, fatty acid oxidation and mitochondrial respiratory function12,13,14. Changes in acetyl-CoA abundance have been shown to affect global histone acetylation and gene expression‎14, 15. Importantly, genetic or pharmacologic disruption of ACLY activity can decrease histone acetylation16. Exogenous acetate can generate acetyl-CoA and maintain global histone acetylation when ACLY generated acetyl-CoA is limiting17.

Fig. 4: TCA cycle regulation of chromatin modifications and DNA methylation.

The activity of the TCA cycle is essential to provide the metabolites that control chromatin modifications and DNA methylation. Specifically, histone acetylation by histone acetyltransferases (HATs) is dependent on the availability of acetyl-CoA, which provides the necessary acetyl groups to enable the reaction. Acetyl-CoA is produced in the cytosol by ACLY using citrate exported from the TCA cycle in mitochondria. α-ketoglutarate (α-KG) is an essential cofactor of 2-OGDD, including the histone demethylases JMJDs and TET DNA demethylases. Succinate is the product of 2-OGDD enzymes reactions and thus, when it accumulates, it works as an antagonist of the reaction. 2-HG and fumarate can also rewire the epigenetic landscape of the cells through inhibition of histone and DNA demethylases.

Full size image

In certain situations, specific genes are preferentially regulated upon changes in acetyl-CoA availability. For example, in glioblastoma multiforme (GBM) cell lines, limited glucose availability diminished acetyl-CoA levels and decreased the expression‎ of genes involved in cell adhesion and migration by controlling the Ca2+-NFAT pathway14, 18. High levels of acetyl-CoA increased influx of calcium into the cells, activating and translocating NFAT to the nucleus. Once in the nucleus, NFAT recruits the lysine acetyltransferase (KAT) p300 to drive the site-specific regulation of H3K27ac and increased the expression‎ of genes related to cell migration and adhesion to the extra-cellular matrix. The acetylation of this specific locus was maintained even in limited acetyl-CoA conditions when NFAT was constitutively active, which suggest that acetyl-CoA levels might not be rate limiting for site-specific histone acetylation. The results also suggest a dual regulation in the chromatin remodeling where histone acetylation can provide binding sites for regulatory proteins, but also specific transcription factors may be required for the acetylation of some histones marks in different contexts. Some transcription factors like Smad2 are regulated by acetylation, so the pool of acetyl-CoA in the cytosol and in the nucleus can also influence gene expression‎ through this mechanism19.

Acetyl-CoA levels affect immune, cancer, and stem cells functions

Elevated histone acetylation as a consequence of high acetyl-CoA levels brings the cells to a pro-anabolic state increasing the expression‎ of genes involved in cell growth and proliferation, including glycolytic enzymes14. Thus, cancer cells upregulate acetyl-CoA generating enzymes like ACLY to increase their proliferative capacity. Remarkably, inhibition of ACLY suppresses tumorigenesis20. The signaling pathways that lead to an increased acetylation of histones in high acetyl-CoA levels seem to vary in different contexts. For instance, recent findings in pancreatic cancer showed that high levels of acetyl-CoA and its use in the meval‎onate pathway favored malignant progression of KRAS mutant acinar cells through the AKT-ACLY signaling axis21.

In other highly proliferative normal cells like T cells, increased cytosolic acetyl-CoA levels are required for histone acetylation to promote interferon-γ (IFNγ) production22. Along these lines, the production of acetyl-CoA by fatty acid β-oxidation regulates lymphangiogenesis through epigenetic changes regulated by the transcription factor PROX123. Histone acetylation has also been linked to macrophages and dentritic cells (DCs) activation. Activated DCs and macrophages are characterized by a truncated TCA cycle that causes citrate levels to accumulate. As a consequence, lipopolysaccharide (LPS)-stimulated macrophages upregulate ACLY increasing cytosolic acetyl-CoA levels24. Upregulation of ACLY through NF-kB and STAT signaling pathways was shown to be necessary for the production of pro-inflammatory molecules, including nitric oxide (NO), ROS, and the prostaglandin E2 (PGE2) in induced macrophages.

Interestingly, the Akt-mTORC1 signaling axis has also been reported to regulate protein levels and activity of ACLY in macrophages activated by the polarizing anti-inflammatory signal IL-425. An increased ACLY activity mediated histone acetylation and transcriptionally induced a subset of genes associated with cellular proliferation and production of chemokines25. These results indicate that a tight coordinated regulation and context-dependent metabolic control of histone acetylation is necessary to drive specific macrophages states. In embryonic stem cell differentiation, as the cells acquire a more quiescent phenotype the levels of acetyl-CoA and histone acetylation decrease15. Additionally, mitochondrial respiratory inhibition in hematopoietic stem cells decreases histone acetylation, which is associated with a block in cellular differentiation26. Overall, these studies highlight that acetyl-CoA is not just a passive acetyl group donor but rather an important signaling molecule involved in the regulation of the activity of specific transcription factors and histone marks that ultimately dictate cellular functions by regulating gene expression‎.

α-ketoglutarate

α-KG, also known as 2-oxoglutarate, is an obligatory co-substrate for 2-oxoglutarate-dependent dioxygenases (2-OGDD), a large group of phylogenetically conserved enzymes, which catalyze hydroxylation reactions on various types of substrates, including proteins, nucleic acids, lipids, and metabolic intermediates producing CO2 and succinate. The activity of 2-OGDD is dependent on the intracellular ratio of α-KG to succinate or other inhibitors such as fumarate or 2-Hydroxyglutarate (2-HG). In addition to α-KG, these hydroxylation reactions require of Fe2+ as a cofactor and O2 as co-substrate. Ascorbic acid (vitamin C) also takes part in these reactions by inducing the reduction of oxidized Fe3+ to Fe2+ and restoring the activity of 2-OGDD enzymes. In humans, 2-OGDD play a key role in physiologically important processes such as responses to hypoxia and chromatin modifications. It is important to note that substrate intracellular concentrations including the levels of α-KG exceed the enzyme binding site affinity27. Thus, we propose that it is the accumulation of inhibitors of 2-OGDD reactions, i.e., succinate, fumarate or 2-HG above α-KG levels that modulate 2-OGDD enzymes to exert biological effects.

α-KG is a key modulator of the hypoxic response

Prolyl-hydroxylases PHD1–3 are 2-OGDD enzymes critical in the regulation of the transcription factor HIF-1, a master regulator of O2 homeostasis. In normoxia, proline residues located in the oxygen-dependent degradation domain of HIF-1α are hydroxylated by PHDs. The hydroxylation of HIF-1α is the signal for the recognition and poly-ubiquitination of HIF-1α by the VHL protein (von Hippel-Lindau tumor suppressor), which targets the protein for degradation in the proteasome. Under limited oxygen conditions or at reduced levels of α-KG or Fe2+, PHDs activity is impaired, resulting in HIF-1α or HIF-2α accumulation and translocation to the nucleus where it promotes changes in the expression‎ of genes related to metabolism, erythropoiesis, and angiogenesis, as well as stem and immune cell function28 (Fig. 5). A combination of decreased oxygen levels and production of mitochondrial ROS diminishes PHDs to increase HIF-1α29. Mitochondrial ROS accumulation under normoxia can also inhibit PHDs to activate HIFs30. As discussed below, TCA cycle intermediates succinate, fumarate and L-2-HG under normoxic conditions can inhibit PHDs31. Interestingly, in the opposite direction, the reactivation of PHDs by increased intracellular α-KG levels in hypoxic cancer cells causes a severe metabolic impairment that lead to cell death32.

Fig. 5: TCA cycle metabolites regulate HIF-α stabilization.

Under normoxia, HIF-α is hydroxylated by prolyl-hydroxylases (PHDs) and targeted for proteasomal degradation by von Hippel-Lindau (pVHL) complex. Under hypoxic conditions, PHDs activity is inhibited preventing HIF-α hydroxylation, which causes its stabilization. HIF-α then translocates to the nucleus where it associates with HIF-1β to activate transcription of HIF target genes involved in metabolism, angiogenesis, erythropoiesis, immune responses, and tumor invasion. In normoxia, ROS released from mitochondria and accumulated levels of the metabolites succinate, fumarate and L-2-HG can inhibit the activity of PHDs causing a pseudohypoxia state.

α-KG has multiple functions in physiology by regulating epigenetic changes

α-KG is also a required substrate of some chromatin-modifying enzymes, including the Jumonji C domain containing lysine demethylases (KDM2-7), which are the major histone demethylases and the ten-eleven translocation hydroxylases (TET1-3) involved in DNA demethylation (Fig. 4). Similar to PHDs, it has been recently reported that KDM6A and KDM5A activities are sensitive to changes in O2 levels33, 34. Histone methylation on single lysine (K) amino acid residues can activate or repress transcription depending on the particular residue and the level of methylation. DNA methylation modifies the chromatic structures and typically decreases gene expression‎ by changing the structure of a single nucleotide. The availability of α-KG has a direct impact on gene expression‎ and thus can modulate cellular fate decision by regulating histones and DNA demethylases. For example, high intracellular levels of α-KG (with the concomitant increase in the α-KG/succinate ratio) are necessary to maintain pluripotency by regulating multiple chromatin modifications35.

In macrophages, an important functional role has been attributed to α-KG in favoring an anti-inflammatory profile while repressing pro-inflammatory responses36. A primary reason for increased glutaminolysis in IL-4-activated macrophages is the increased production of α-KG that contributes to the acquisition of an anti-inflammatory phenotype by altering the activity of the histone demethylase Jmjd3. However, in classical macrophages activation following LPS stimulation, low levels of α-KG was found to dampen a pro-inflammatory response36. Mechanistically, α-KG suppresses IKKβ activation that is required for the pro-inflammatory effects driven by the nuclear factor-κB (NF-κB) pathway in a PHD activity-dependent manner. Furthermore, this same study described that α-KG produced from glutaminolysis promotes LPS-induced endotoxin tolerance36. These results highlight that targeting pathways involved in α-KG production offers attractive therapeutically opportunities in diseases associated with macrophage malfunction.

2-Hydroxyglutarate (2-HG)2-HG production and removal

Although 2-HG is not part of the TCA cycle, this α-KG derived metabolite can be generated by enzymes in mitochondrial matrix and cytosol. 2-HG competitively inhibits 2-OGDDs and exists in two isomers: L-2-HG and D-2-HG. Targets of both 2-HG include histone demethylases, TET enzymes that participate in DNA methylation and PHDs37,38,39. L- or D-2-HG abundance is limited in normal tissues however they can reach to millimolar concentrations under certain pathologic conditions40, 41. The isomer D-2-HG is accumulated as a consequence of gain-of-function mutations in the cytosolic and mitochondrial isoforms of IDH42, 43. Interestingly, IDH1 and IDH2 are the most frequently mutated metabolic genes in human cancer and are found in multiple tumor types, including gliomas, acute myelogenous leukemias (AMLs), and myelodysplastic syndromes (MDS)42,43,44,45. Single-point mutation of R132 in IDH1 or R172 in IDH2 reorganizes the active site, causing an increased affinity for NADPH to promote α-KG reduction at the expense of its principal substrate (isocitrate). The observation of D-2-HG accumulation in these tumors prompted the community to use the term oncometabolite for the first time. Currently, D-2-HG is being used as a biomarker to monitor the disease progression, and mutants IDH1/IDH2-specific inhibitors are in clinical trials for AML and glioma. Additionally, D-2-HG can be produced by the promiscuous activity of phosphoglycerate dehydrogenase (PHGDH), an enzyme frequently overexpressed in cancer. Normally, this enzyme catalyzes the first step in the de novo serine biosynthesis pathway where 3-phosphoglycerate (3PG) is converted to 3-phosphohydroxypyruvate (3PHP) coupled with NAD + reduction. However, in human breast cancer cell lines, PHDGH has been described to convert α-KG to D-2-HG in a NADH-dependent manner46.

Malate dehydrogenases (MDH) 1 or 2 and lactate dehydrogenases (LDH) A or C can generate L-2-HG47,48,49 (Fig. 6). MDH2 and MDH1 normally catalyze the conversion of OAA into malate in mitochondria and cytosol, respectively. The conversion of α-KG to L-2-HG by MDHs is coupled with NADH oxidation to NAD + . In normal conditions, LDH catalyzes the interconversion of lactate and pyruvate. However, LDHA under hypoxia can generate L-2-HG. The ability of cells to increase L-2-HG in hypoxic conditions to regulate histone methylation levels, including H3K9me3 and to reduce cellular reductive stress by inhibiting key metabolic pathways indicates an important physiological role of L-2-HG48, 50. Acidic pH has also been described as a potent driver of L-2-HG production by favoring the promiscuous activity of LDHA and MDHs enzymes that utilize α-KG as an alternative substrate51, 52. Mechanistically, acidic pH generates a protonated form of α-KG that preferentially binds to LDHA51. An independent study showed that inhibition of enzymes involved in converting L-2-HG back to α-KG also accounts for the resulting L-2-HG accumulation observed in acidic microenvironments52. Importantly, both studies reported that accumulated levels of L-2-HG in acidic pH lead to stabilization of HIF-1α in normoxia. As α-KG availability directly influences the production of L-2-HG, these results bring the possibility of manipulating α-KG levels as a potential therapeutic strategy in acidosis.

Fig. 6: L-2-hydroxyglutarate (L-2-HG) regulates Treg cells function.

Mitochondrial malate dehydrogenase (MDH2), its cytosolic counterpart (MDH1) and lactate dehydrogenases (LDH) A or C in the cytosol can exhibit enzyme promiscuity and catalyze α-KG reduction to L-2-HG. The reaction is coupled with NADH oxidation to NAD + . L-2-hydroxyglutarate dehydrogenase (L-2-HGDH) converts L-2-HG back to α-KG in mitochondria. Accumulated levels of L-2-HG inhibits the activity of TETs, which are enzymes involved in regulating DNA demethylation. TETs consume oxygen and α-KG as co-substrates producing CO2 and succinate. The reaction requires of Fe2+ as a cofactor. This mechanism has been observed to specifically repress immunosuppressive genes when mitochondrial complex III is impaired.

Pathways for 2-HG removal are evolutionarily conserved. 2-HG can be converted back to α-KG through the action of the FAD-linked enzyme 2-hydroxyglutarate dehydrogenase (2-HGDH). Humans have two variants of this enzyme: D-2-hydroxyglutarate dehydrogenase (D-2-HGDH) and L-2-hydroxyglutarate dehydrogenase (L-2-HGDH), and both of them are located in the mitochondria. A deficiency in either of these two enzymes caused by germline transmission of homozygous mutations can lead to a disease known as 2-hydroxyglutaric acidurias (2-HGA). D-2-HGA is a rare disease, with symptoms, including macrocephaly, cardiomyopathy, mental retardation, hypotonia, and cortical blindness. L-2-HGA is a rare neurodegenerative disorder that causes hypotonia, tremors, epilepsy, mental retardation, and psychomotor regression. Notably, it has been reported that children with L-2-HGA developed medulloblastoma and glioblastoma multiforme, as well as Wilms tumor53, 54. Moreover, increased L-2-HG levels resulting from reduced expression‎ of L-2-HGDH were observed in renal cancer, which suggest a potential tumorigenic effect for this isomer as well55.

2-HG regulates immune and stem cells functions

All the promiscuous reactions leading to L-2-HG production share in common the oxidation of NADH, a driver of the reactions when it accumulates. Elevated NADH levels are a direct consequence of mitochondrial dysfunction, since one of the essential functions of complex I is NAD + recycling. Thus, inhibition of mitochondrial complex III in cancer cells has been shown to increase the production of 2-HG56. Likewise, disruption of complex III activity in hematopoietic stem cells (HSC) promoted an increase in the 2-HG levels26. Noteworthy, fetal HSC kept their proliferative capacity in respiration-deficient conditions but were unable to differentiate. More recently, it has been reported that loss of mitochondrial complex III in regulatory T cells (Tregs) resulted in a buildup of 2-HG57. Tregs are key mediators of immunological tolerance and homeostasis. In this study, mice lacking functional OXPHOS specifically in Tregs developed a lethal inflammatory disorder causing mice death between the third and the fourth week of life. Interestingly, complex III-deficient Tregs lost their suppressive capacity while their proliferation and survival remained unaffected. The transcriptomic profile of complex III-deficient Tregs compared to wild-type showed differences in the expression‎ of immune regulatory molecules while maintaining stable FOXP3 expression‎, the master regulatory transcription factor of Tregs. In both contexts, in HSCs and Tregs, accumulated 2-HG levels seem to alter the cellular function, which is associated with hypermethylation of specific histone marks and DNA methylation.

Interestingly, in Tregs the loci of differentially down-regulated genes exhibited DNA methylation, suggesting a potential role for 2-HG in contributing to the autoimmune pathological phenotype of these mice. Accumulated 2-HG due to defective mitochondrial function then has the ability to mediate cellular signaling by directly and specifically impacting the expression‎ of immunosuppressive genes to regulate Tregs without affecting other biological outcomes of this T cells subset (Fig. 6). This study adds more evidence on the interesting link between 2-HG levels and the regulation of cell fate in immune cells. For instance, D-2-HG has been shown to favor T helper 17 (TH17) cells differentiation, a T-cell population that promotes inflammation by increasing DNA methylation levels at the Foxp3 locus, which represses the differentiation of naïve CD4 + T cells towards induced Tregs58. Glutamate conversion to α-KG by the aspartate aminotransferase GOT1 was found to be essential for D-2-HG generation and thus for the regulation of TH17 and induced Tregs fate. Finally, in mouse CD8 + T cells, elevated levels of L-2-HG in response to T-cell receptor triggering have been reported to favor their differentiation and antitumor capacity41. Since the expression‎ of 2-OGDDs likely is different among different tissues, the effects of 2-HG are likely to be context dependent. Collectively, 2-HG, a metabolite that gets accumulated through abnormal metabolic functions, exert most of the effects through non-metabolic mechanisms.

SuccinateSuccinate as an oncometabolite

Succinate is a TCA cycle metabolite that has multiple intracellular functions, as well as organismal functions. Succinate is considered an oncometabolite that accumulates due to inactivating mutations in SDH. SDH mutations are commonly found in several cancers, including hereditary paraganglioma (PGL) and pheochromocytoma (PCC)59,60,61,62. Succinate accumulation has an impact in gene expression‎ regulation and promotes tumorigenesis through two main mechanisms. Succinate is the product of 2-OGDD enzymes reactions and thus its accumulation inhibits these enzymes. Consequently, changes in succinate have profound effects in histones and DNA methylation, changing the epigenetic landscape of the cells and gene expression‎ (Fig. 4). In paraganglioma, mutations in the SDH genes were found to establish a DNA hypermethylator phenotype63. SDH-deficient cells displayed an increased 5-mC/5-hmC ratio and histone methylation, an effect that was reversed by exogenous addition of α-KG to the culture medium in vitro. DNA hypermethylation was associated with the silencing of key genes involved in neuroendocrine differentiation favoring malignancy. Further studies will determine if analogously to the effects of acetyl-CoA fluctuations in histone acetylation, particular programs get activated to promote histones or DNA methylation at specific loci instead of global changes in the presence of high succinate levels. Additionally, succinate can inhibit PHDs, promoting the accumulation of HIF-1α in the presence of oxygen, a phenomenon known as pseudohypoxia64.

Succinate has an important function in the regulation of innate immunity

The metabolic profile of LPS treated macrophages revealed a high abundance of succinate, which induces HIF-1α stabilization as well as the transcriptional activation of the pro-inflammatory cytokine IL-1β65, 66. Succinate oxidation by complex II is necessary to drive the production of IL-1β. Macrophages lacking the B subunit of SDH showed decreased IL-1β production and HIF-1α stabilization when stimulated with LPS. The inhibition of SDH in vivo diminished LPS-induced endotoxemia. LPS stimulation of both succinate oxidation to promote reduction of the ubiquinone pool accumulation and an increase in the mitochondrial membrane potential (ψm) raised the production of mitochondrial ROS through complex I-dependent reverse electron transfer (RET). The excess entry of electrons in the ubiquinone pool from complex II increases the propensity of electrons to go backward to complex I when the mitochondrial membrane potential is high. This triggers the generation of superoxide production from complex I. Thus, the addition of mitochondrial complex I or II inhibitors decrease IL-1β production and HIF-1α stabilization. The overexpression‎ of an alternative oxidase (AOX), which is able to help ease up the excess of electrons in the ubiquinone pool, decreases LPS induction of ROS levels and production of IL-1β in macrophages. An independent study showed that E. coli or S. enterica-challenged macrophages stimulate mitochondrial complex II activity at the expense of complex I activity further supporting an importing role for SDH in promoting a pro-inflammatory phenotype67. The inhibition of complex II by treating mice with NPA, hampered the pro-inflammatory function of macrophages. Succinate-driven RET induction of ROS is not only limited to immune cells as ischemia reperfusion injury in heart and brain requires RET68, 69. Currently, strategies to diminish RET by using complex II or I inhibitors are being tested in the clinic.

Succinate has organismal effects

Beyond its intracellular signaling role, succinate release has been shown to signal through the G-protein-coupled receptor succinate receptor 1 (SUCNR1). The ligand for this receptor was unknown up until 2004 when He et al.70 described that binding of succinate to SUCNR1 induces an hypertensive effect by modulating the renin-angiotensin system. Since then, multiple signaling cascades have been described upon succinate binding to the receptor in various cell types, including dendritic cells and macrophages where it seems to contribute to their functionality in driving inflammation71. Taken together, these studies highlight that succinate oxidation is central and a main regulator of the immune effector cells functions. Finally, it is worth noting that recent findings describe succinate as a systemic molecule that activates thermogenesis in brown adipocytes upon cold exposure72. In this condition, brown adipocytes exhibited a high avidity to uptake elevated circulating succinate that was then oxidized by SDH increasing ROS levels and UCP1 activity. It will be interesting to see if additional TCA cycles metabolites can signal systemic responses in other contexts.

Fumarate

Fumarate promotes tumor growth through diverse signaling functions

Accumulation of fumarate to millimolar levels due to inactivating mutations of fumarate hydratase (FH) is found in the genetic disorder fumaric aciduria, as well as the hereditary leiomyomatosis and renal cell cancer (HLRCC)73, in which fumarate causes hypermethylation of DNA by inhibiting TET enzymes to trigger epithelial-mesenchymal transition (EMT)74. Fumarate is a potent inhibitor of 2-OGDD enzymes75, 76 and thus, it also contributes to the pseudohypoxia state that characterized FH-deficient tumors by allowing HIF-1α stabilization even under normoxic conditions through the inhibition of the PHDs enzymes77. Fumarate is an electrophile and can cause succination of proteins, a process where fumarate binds and inactivates reactive thiol protein cysteine residues. This protein modification was first identified in the context of diabetes where elevated levels of fumarate contribute to a progressive deterioration of β cells function78, 79. Specifically, succination of critical cysteine in GAPDH, GMPR and PARK7/DJ-1 were found in mice lacking Fh1 that develop progressive glucose intolerance and diabetes at around week 6–8 after birth. In HLRCC, fumarate drives the succination of KEAP1, the negative regulator of the master antioxidant transcription factor NRF280,81,82. Other studies have shown that high levels of fumarate increase ROS signaling by binding glutathione83, 84. Succination following fumarate accumulation has also been shown to cause the loss of the mitochondrial aconitase (ACO2) activity, which is crucial for iron–sulfur cluster binding85. Finally, the iron-responsive element binding protein 2 (IRP2) that promotes the transcription of transferrin and the family of iron–sulfur (Fe-SA) cluster biogenesis proteins have also been described to be succinated when fumarate accumulates in cancer cells86.

Fumarate is an anti-inflammatory signal

Fumarate also functions as an immunomodulator by controlling chromatin modifications (Fig. 4) and regulating protein succination. Specifically, the accumulation of fumarate through glutamine anaplerosis in response to pro-inflammatory insults has been shown to be necessary for trained immunity and inflammation by inhibiting KDM5 histone demethylase activity87. The inhibition of KDM5 increases the levels of H3K4me3, a marker of active gene transcription at the promoters of Tnfα and Il6 cytokines. Fumarate has also been shown to accumulate in LPS-activated macrophages65, 88. Furthermore, fumarate derivatives like dimethyl fumarate (DMF), a potent electrophile, can regulate T-cell functions89. DMF is currently being used in the clinic to treat autoimmune conditions, including multiple sclerosis (MS) and psoriasis. Using an unbiased proteomic approach, Blewett et al.89 discovered that different proteins in T cells are sensitive to covalent modifications of cysteines induced by DMF. Among these proteins, the authors identified protein kinase C θ (PKCθ) that can no longer associate with the costimulatory receptor CD28 in the presence of DMF preventing T-cell activation. Importantly, the authors showed how a mutation of these DMF-sensitive cysteines impaired PKCθ-CD28 interactions and T-cell activation recapitulating the effects observed with DMF89. Recently, succination of GAPDH that leads to the inactivation of its enzymatic activity has also been identified in peripheral blood mononuclear cells (PBMCs) from mice and patients with MS treated with DMF90. Endogenous fumarate was also found to inhibit GAPDH through succination in mouse and human macrophages. These results suggest that DMF modulate the activity of immune cells by negatively regulating glycolysis, a metabolic pathway required for the activation and proliferation of different subsets of T cells91.

ItaconateItaconate is an important immunomodulator and antibacterial agent

Itaconate is derived from the decarboxylation of the TCA cycle intermediate cis-aconitate. Accumulation of itaconate occurs in the lungs of mice infected with Mycobacterium tuberculosis92 and in macrophages activated with LPS93. The immune-responsive gene 1 protein (IRG1) is the enzyme responsible for itaconate production. IRG1 was consequently renamed as cis-aconitate decarboxylase after this discovery. IRG1 loss of function in macrophages infected with Salmonella enterica had reduced aconitate levels and decreased anti-bactericidal activity94. The anti-bactericidal properties of itaconate are derived from its ability to inhibit isocitrate lyase, a key enzyme of the glyoxylate shunt, a pathway required for the survival of many parasites especially under poor glucose conditions. LPS also induces IRG1 to trigger the accumulation of itaconate, which consequently limits IL-1β production95, 96.

Itaconate induces electrophilic stress

Initially, itaconate was shown to inhibit SDH thus limiting succinate oxidation and this was assumed to be the primary mechanism by which itaconate limits inflammation95, 96. However, itaconate is a relatively weak competitive inhibitor of SDH raising the possibility that there are other mechanisms to account for itaconate’s anti-inflammatory activity. Recent studies indicate that itaconate activates pathways downstream of the antioxidant transcription factor NRF2, as well as NRF2 independent mechanisms that contribute to its anti-inflammatory properties in activated macrophages. Itaconate has electrophilic properties that can disrupt KEAP1 interaction with NRF297. Itaconate can also inhibit the NF-κB inhibitor IκBζ to dampen LPS stimulation of inflammation98. Interestingly, derivatives of itaconate such as octyl-itaconate or dimethyl-itaconate, which are strong electrophiles, diminish pro-inflammatory cytokine production in vitro and in vivo97, 98. The administration of dimethyl-itaconate in vivo ameliorated the outcome of an IL-17–IκBζ-driven skin pathology in a mouse model of psoriasis. These results significantly extended the knowledge of itaconate biology and raised the possibility of using itaconate derivatives as a therapeutic agent in autoimmune diseases. However, since high levels of itaconate might cause a B12 deficiency, the safety of long-term exposures to itaconate needs to be eval‎uated99.

Conclusion

In the past two decades, mitochondrial biology has undergone a renaissance partly due to the appreciation that mitochondria have important biological functions beyond ATP and macromolecules production. Indeed, mitochondria have evolved from passive to active players in determining cell fate and function. Mechanistically, TCA cycle metabolites have been demonstrated to control transcription factors and chromatin modifications to change cell function and fate. However, in many contexts the molecular details of how changes in TCA cycle metabolites abundance affect the expression‎ of specific genes remains to be elucidated. Future investigations might also discover additional mechanisms by which TCA cycle metabolites exert signaling functions beyond post-translational modifications. Emerging evidence indicates that beyond cell autonomous functions, TCA cycle metabolites control physiology through non-cell autonomous functions. Discovering systemic effects of metabolites and their role in communicating different parts of the body will be of much interest for the field in the upcoming years. A fascinating development is the use of derivatives of TCA cycle metabolites to ameliorate inflammatory diseases in humans. We hope to see more of the recent findings of TCA cycle signaling effects being translated into the clinic. Going forward, we predict that TCA cycle metabolites will continue to shed new light on biology, physiology, and diseases.

References

1. Chandel, N. S. Evolution of mitochondria as signaling organelles. Cell Metab. 22, 204–206 (2015).

   Article CAS PubMed Google Scholar 

2. Liu, X., Kim, C. N., Yang, J., Jemmerson, R. & Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147–157 (1996).

   Article CAS PubMed Google Scholar 

3. Chandel, N. S. et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl Acad. Sci. USA 95, 11715–11720 (1998).

   Article ADS CAS PubMed PubMed Central Google Scholar 

4. Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121–135 (2018).

   Article CAS PubMed Google Scholar 

5. West, A. P. & Shadel, G. S. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat. Rev. Immunol. 17, 363–375 (2017).

   Article CAS PubMed PubMed Central Google Scholar 

6. DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).

   Article ADS PubMed PubMed Central CAS Google Scholar 

7. Mullen, A. R. et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481, 385–388 (2011).

   Article ADS PubMed PubMed Central CAS Google Scholar 

8. Mashimo, T. et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159, 1603–1614 (2014).

   Article CAS PubMed PubMed Central Google Scholar 

9. Schug, Z. T. et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27, 57–71 (2015).

   Article CAS PubMed PubMed Central Google Scholar 

10. Shi, L. & Tu, B. P. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr. Opin. Cell Biol. 33, 125–131 (2015).

    Article CAS PubMed PubMed Central Google Scholar 

11. Sivanand, S., Viney, I. & Wellen, K. E. Spatiotemporal control of acetyl-CoA metabolism in chromatin regulation. Trends Biochem. Sci. 43, 61–74 (2018).

    Article CAS PubMed Google Scholar 

12. Martinez-Reyes, I. et al. TCA cycle and mitochondrial membrane potential are necessary for diverse biological functions. Mol. Cell 61, 199–209 (2016).

    Article CAS PubMed Google Scholar 

13. McDonnell, E. et al. Lipids reprogram metabolism to become a major carbon source for histone acetylation. Cell Rep. 17, 1463–1472 (2016).

    Article CAS PubMed PubMed Central Google Scholar 

14. Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20, 306–319 (2014).

    Article CAS PubMed PubMed Central Google Scholar 

15. Moussaieff, A. et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 21, 392–402 (2015).

    Article CAS PubMed Google Scholar 

16. Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076–1080 (2009). A study that uncovered one important mechanism that connects the TCA cycle and chromatin modifications.

    Article ADS CAS PubMed PubMed Central Google Scholar 

17. Zhao, S. et al. ATP-citrate lyase controls a glucose-to-acetate metabolic switch. Cell Rep. 17, 1037–1052 (2016).

    Article CAS PubMed PubMed Central Google Scholar 

18. Lee, J. V. et al. Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca(2+)-NFAT signaling. Genes Dev. 32, 497–511 (2018).

    Article CAS PubMed PubMed Central Google Scholar 

19. Rios Garcia, M. et al. Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence. Cell Metab. 26, 842–855 e5 (2017).

    Article CAS PubMed Google Scholar 

20. Hatzivassiliou, G. et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311–321 (2005).

    Article CAS PubMed Google Scholar 

21. Carrer, A. et al. Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis. Cancer Disco. 9, 416–435 (2019).

    Article Google Scholar 

22. Peng, M. et al. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354, 481–484 (2016).

    Article ADS CAS PubMed PubMed Central Google Scholar 

23. Wong, B. W. et al. The role of fatty acid beta-oxidation in lymphangiogenesis. Nature 542, 49–54 (2017). This report describes a key physiological function of acetyl-CoA in lymphangiogenic endothelial cells mediated by histone acetylation.

    Article ADS CAS PubMed Google Scholar 

24. Infantino, V., Iacobazzi, V., Palmieri, F. & Menga, A. ATP-citrate lyase is essential for macrophage inflammatory response. Biochem. Biophys. Res. Commun. 440, 105–111 (2013).

    Article CAS PubMed Google Scholar 

25. Covarrubias, A. J. et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife 5, e11612 (2016).

    Article PubMed PubMed Central Google Scholar 

26. Anso, E. et al. The mitochondrial respiratory chain is essential for haematopoietic stem cell function. Nat. Cell Biol. 19, 614–625 (2017). A report that shows that changes in the abundance of metabolites including L-2HG due to the impairment of mitochondrial function results in hematopoietic stem cells unable to differentiate.

    Article CAS PubMed PubMed Central Google Scholar 

27. Park, J. O. et al. Metabolite concentrations, fluxes and free energies imply efficient enzyme usage. Nat. Chem. Biol. 12, 482–489 (2016).

    Article CAS PubMed PubMed Central Google Scholar 

28. Semenza, G. L. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399–408 (2012).

    Article CAS PubMed PubMed Central Google Scholar 

29. Chandel, N. S. et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 275, 25130–25138 (2000).

    Article CAS PubMed Google Scholar 

30. Patten, D. A. et al. Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol. Biol. Cell 21, 3247–3257 (2010).

    Article CAS PubMed PubMed Central Google Scholar 

31. Kaelin, W. G. Jr. & Ratcliffe, P. J. Oxygen sensing by metazoa